Skip to content

HYPOTHERMIA INDUCED VIA AUTOMATED PERITONEAL LAVAGE FOLLOWING CARDIAC ARREST OR ACUTE ST-ELEVATION MYOCARDIAL INFARCTION

HYPOTHERMIA INDUCED VIA AUTOMATED PERITONEAL LAVAGE FOLLOWING CARDIAC ARREST OR ACUTE ST-ELEVATION MYOCARDIAL INFARCTION - Therapeutic hypothermia following myocardial infarction.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON36573
Enrollment
20
Registered
2010-07-07
Start date
2010-07-20
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiac arrest

Interventions

Cooling and maintaining mild hypothermia using an automated peritoneal lavage system.

Sponsors

Velomedix, Inc
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. cardiac arrest (in-hosptial or out-of hospital) with return of spontaneous circulation 2. myocardial infarction (18-85 years): STEMI

Exclusion criteria

Exclusion criteria: 1. Subject is known to be pregnant; 2. Subject is obeying commands; 3. Subject has a known history of abdominal surgery, peritonitis, or currently undergoing regular peritoneal dialysis; 4. Subject has a known history of severe chronic obstructive pulmonary disorder (COPD) (i.e., requires supplemental home oxygen); 5. Subject has a known anatomic abnormality that in the physician*s opinion will create additional risk when treating the patient (i.e., profound obesity, abdominal aortic aneurysm, abdominal wall hernia, spinal deformity, etc.); 6. Subject has a known severe neurological dysfunction evident prior to the presenting acute event; 7. Subject has known significant concomitant illness (other than cardiac arrest) with a life expectancy of

Design outcomes

Primary

MeasureTime frame
Safety (composite of new-onset serious adverse event(s), feasibility, side effects, and efficacy (infarct size).

Secondary

MeasureTime frame
* CA subgroup (with or without STEMI): Percentage of subjects with good neurologic outcome (Glasgow Outcome Score of 4 or 5] at any time during their hospital stay) and at 6 months * STEMI subgroup (with or without CA): Myocardial infarct size at 14 days (± 3 days) post-procedure as measured by Tc99m Sestamibi single photon emission computed tomography (SPECT). * All cause mortality through 6 months post-procedure. * Device success defined as the capability of the device to decrease subject core temperature to 34°C within 30 minutes of treatment. * STEMI subgroup (without CA): MACE at 30 days (± 7 days) as defined by death or non-fatal reinfarction or ischemia-driven TVR.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)